Virologist Joins Cancervax As Senior Scientific Advisor
27 Jan 2026 //
GLOBENEWSWIRE
Immunologist Joins CancerVax As Senior Scientific Advisor
07 Jan 2026 //
GLOBENEWSWIRE
CancerVax Highlights Key 2025 Scientific, Strategic Milestones
23 Dec 2025 //
GLOBENEWSWIRE
CancerVax: Nanoparticles Succeed in Animal Cancer Studies
17 Dec 2025 //
GLOBENEWSWIRE
Cancervax Precision Therapy Spares Healthy Liver Cells
14 Oct 2025 //
GLOBENEWSWIRE
Biotech Veteran Joins CancerVax as Strategic Advisor
03 Sep 2025 //
GLOBENEWSWIRE
Cancervax Files Key Patent Application for Milestone Achievements
26 Aug 2025 //
GLOBENEWSWIRE
Recent CancerVax Breakthrough Discussed by Scientists
19 Aug 2025 //
GLOBENEWSWIRE
Cancervax Tricks Immune Cells to Attack Cancer Cells
05 Aug 2025 //
GLOBENEWSWIRE
CancerVax Nanoparticle Targets Cancer Cells, Spares Others
19 Jun 2025 //
GLOBENEWSWIRE
CancerVax Creates Cell-Targeting Nanoparticle
05 Jun 2025 //
GLOBENEWSWIRE
CancerVax Scientists on Cytiva`s "Discovery Matters" Podcast
03 Jun 2025 //
GLOBENEWSWIRE
Top Biotech Exec Joins CancerVax as Chief Scientific Advisor
27 Feb 2025 //
GLOBENEWSWIRE
CancerVax Announces Successful Tests of its Smart mRNA Technology
25 Feb 2025 //
GLOBENEWSWIRE
CancerVax Passes First Test with Flying Colors
20 Dec 2024 //
GLOBENEWSWIRE
CancerVax Targets Hard to Treat Pancreatic Cancer
11 Dec 2024 //
GLOBENEWSWIRE
CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform
27 Aug 2024 //
GLOBENEWSWIRE
CancerVax Achieves Universal Vaccine Targeting Milestone Using Nobel Chemistry
21 May 2024 //
GLOBENEWSWIRE
CancerVax Launches $5 Million Funding Round
03 Apr 2024 //
GLOBENEWSWIRE
CancerVAX CEO Ryan Davies Discussed Cancer Immunotherapy with UCLA Scientist
24 Aug 2023 //
GLOBENEWSWIRE
Professor Jonathan Lakey Joins CancerVAX Board of Advisors
26 Jul 2023 //
GLOBENEWSWIRE
CancerVAX Reports Significant Progress on Universal Cancer Vaccine Devp at UCLA
27 Jun 2023 //
GLOBENEWSWIRE
Biotech Executive Michael Smith Discusses the FDA Drug Development
16 Jun 2023 //
GLOBENEWSWIRE
CancerVAX Launches $10 Million Funding Round
14 Jun 2023 //
GLOBENEWSWIRE
CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment
12 Jun 2023 //
GLOBENEWSWIRE
Ryan Davies and Raymond Vennare Discuss the Cancer Fighting Role of Universities
06 Jun 2023 //
GLOBENEWSWIRE
Dinesh Patel Discusses Medical Devices with CancerVAX CEO Ryan Davies
17 May 2023 //
GLOBENEWSWIRE
Former Pfizer Legal Counsel Discusses Gene Therapy with CancerVAX CEO
20 Apr 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support